Viewing Study NCT05337267


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2025-12-25 @ 10:49 PM
Study NCT ID: NCT05337267
Status: COMPLETED
Last Update Posted: 2023-08-21
First Post: 2022-03-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I Study of Sintilimab in Healthy Chinese Male Subjects
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module